1024免费一级欧美片在线观看_久久免费精品视频互動交流_国国产无套粉嫩白浆在线_饥渴难耐的浪荡艳妇_亚洲国产日韩一区在线_欧美激情性爱吧_精品人妻少妇av嫩草_嗯啊不要视频_另类欧美亚洲综合_网友自拍亚洲无码另类

杭州昊鑫生物科技股份有限公司
網(wǎng)站標(biāo)題
搜索

取消

清空記錄

歷史記錄

清空記錄

歷史記錄

清空記錄

歷史記錄

杭州昊鑫生物科技股份有限公司
    當(dāng)前位置:
  • 首頁(yè)>
  • 產(chǎn)品中心>
  • MCE>
  • Tamoxifen(他莫昔芬)

產(chǎn)品中心

Tamoxifen(他莫昔芬)

分享到微信

×
Tamoxifen (ICI 47699) 是一種口服有效的,選擇性雌激素受體 (estrogen receptor) 調(diào)節(jié)劑 (SERM),可阻斷乳腺細(xì)胞中的雌激素作用,并可激活其他細(xì)胞,如骨骼,肝臟和子宮細(xì)胞中的雌激素活性。Tamoxifen 是一種有效的 Hsp90 激活劑,可增強(qiáng) Hsp90 分子伴侶 ATPase 的活性。Tamoxifen 還可以有效抑制傳染性 EBOV Zaire 和 Marburg (MARV),IC50 分別為 0.1 μM 和 1.8 μM。Tamoxifen 可以激活自噬 (autophagy),誘導(dǎo)凋亡 (apoptosis)。Tamoxifen 還可以誘導(dǎo) CreER(T2) 轉(zhuǎn)基因小鼠的基因敲除。

貨號(hào):HY-13757A
CAS:10540-29-1
參數(shù)品牌:MCE
產(chǎn)品參數(shù)
品牌:MCE
型號(hào):HY-13757A
起訂量:1
規(guī)格::1g
價(jià)格::¥690
我知道了
在線客服
產(chǎn)品詳情

生物活性

Tamoxifen (ICI 47699) is an orally active, selective estrogen receptor modulator (SERM) which blocks estrogen action in breast cells and can activate estrogen activity in other cells, such as bone, liver, and uterine cells[1][2][3]. Tamoxifen is a potent Hsp90 activator and enhances the Hsp90 molecular chaperone ATPase activity. Tamoxifen also potent inhibits infectious EBOV Zaire and Marburg (MARV) with IC50 of 0.1 μM and 1.8 μM, respectively[5]. Tamoxifen activates autophagy and induces apoptosis[4]. Tamoxifen also can induce gene knockout of CreER(T2) transgenic mouse[6


IC50 & Target[1][4]

Estrogen receptor

HSP90


體外研究(In Vitro)

Tamoxifen (ICI 47699) shows strong inhibition of MCF-7 cells (EC50=1.41 μM) and to a lesser extent the T47D cells (EC50=2.5 μM) but does not affect the MDA-MB-231 cells


體內(nèi)研究(In Vivo)

Injection of pre-mutant mice with Tamoxifen (75 mg/kg; injected for 5 days at 6 weeks of age) results in the excision of the floxed exon and, thus, in a gene knockout

Animal Model:Aldh1l1-cre/ERT2 x Ai95 mice

Dosage:75 mg/kg

Administration:Injected for 5 days at 6 weeks of age

Result:Resulted in the excision of the floxed exon and a gene knockout.


中文名稱

他莫昔芬;三苯氧胺;它莫西芬


運(yùn)輸條件

Room temperature in continental US; may vary elsewhere


儲(chǔ)存方式

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)


溶解性數(shù)據(jù)

DMSO : 62.5 mg/mL (168.23 mM; ultrasonic and warming and heat to 60°C)

Ethanol : 50 mg/mL (134.59 mM; Need ultrasonic)

配制儲(chǔ)備液
濃度溶劑體積質(zhì)量1 mg5 mg10 mg
1 mM2.6917 mL13.4586 mL26.9172 mL
5 mM0.5383 mL2.6917 mL5.3834 mL
10 mM0.2692 mL1.3459 mL2.6917 mL
*

請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;一旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。
儲(chǔ)備液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C 儲(chǔ)存時(shí),請(qǐng)?jiān)?6 個(gè)月內(nèi)使用,-20°C 儲(chǔ)存時(shí),請(qǐng)?jiān)?1 個(gè)月內(nèi)使用。


請(qǐng)根據(jù)您的實(shí)驗(yàn)動(dòng)物和給藥方式選擇適當(dāng)?shù)娜芙夥桨?。以下溶解方案都?qǐng)先按照 In Vitro 方式配制澄清的儲(chǔ)備液,再依次添加助溶劑:

——為保證實(shí)驗(yàn)結(jié)果的可靠性,澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;體內(nèi)實(shí)驗(yàn)的工作液,建議您現(xiàn)用現(xiàn)配,當(dāng)天使用; 以下溶劑前顯示的百
分比是指該溶劑在您配制終溶液中的體積占比;如在配制過(guò)程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過(guò)加熱和/或超聲的方式助溶

  • 1.


    請(qǐng)依序添加每種溶劑: corn oil

    Solubility: 40 mg/mL (107.67 mM); Clear solution; Need ultrasonic


  • 2.


    請(qǐng)依序添加每種溶劑: 30% PEG400  0.5% Tween80  5% Propanediol  64.5%H2O

    Solubility: 5 mg/mL (13.46 mM); Suspended solution; Need ultrasonic


  • 3.


    請(qǐng)依序添加每種溶劑: 10% EtOH    40% PEG300    5% Tween-80    45% saline

    Solubility: 2.5 mg/mL (6.73 mM); Suspended solution; Need ultrasonic


  • 4.


    請(qǐng)依序添加每種溶劑: 10% EtOH    90% corn oil

    Solubility: ≥ 2.5 mg/mL (6.73 mM); Clear solution


  • 5.


    請(qǐng)依序添加每種溶劑: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.08 mg/mL (5.60 mM); Clear solution


  • 6.


    請(qǐng)依序添加每種溶劑: 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: 2.08 mg/mL (5.60 mM); Suspended solution; Need ultrasonic


  • 7.


    請(qǐng)依序添加每種溶劑: 10% DMSO    90% corn oil

    Solubility: ≥ 2.08 mg/mL (5.60 mM); Clear solution


  • 8.


    請(qǐng)依序添加每種溶劑: 5% DMSO    40% PEG300    5% Tween-80    50% saline

    Solubility: ≥ 0.83 mg/mL (2.23 mM); Clear solution


  • 9.


    請(qǐng)依序添加每種溶劑: 5% DMSO    95% (20% SBE-β-CD in saline)

    Solubility: 0.83 mg/mL (2.23 mM); Suspended solution; Need ultrasonic



參考文獻(xiàn)

[1]. Osborne CK. Tamoxifen in the treatment of breast cancer. N Engl J Med. 1998 Nov 26;339(22):1609-18.

[2]. Hawariah A, et al. In vitro response of human breast cancer cell lines to the growth-inhibitory effects of styrylpyrone derivative (SPD) and assessment of its antiestrogenicity. Anticancer Res. 1998 Nov-Dec;18(6A):4383-6.

[3]. Jun Nagai, et al. Hyperactivity with Disrupted Attention by Activation of an Astrocyte Synaptogenic Cue. Cell. 2019 May 16;177(5):1280-1292.e20.

[4]. Zhao R, et al. Tamoxifen enhances the Hsp90 molecular chaperone ATPase activity. PLoS One. 2010 Apr 1;5(4):e9934.

[5]. Kedjouar B, et al. Molecular characterization of the microsomal tamoxifen binding site. J Biol Chem. 2004 Aug 6;279(32):34048-61.

[6]. Feil S, et, al. Inducible Cre mice. Methods Mol Biol. 2009;530:343-63.

[7]. Laura Cooper, et al. Screening and Reverse-Engineering of Estrogen Receptor Ligands as Potent Pan-Filovirus Inhibitors. J Med Chem. 2020 Sep 4.



Data Sheet

https://file.medchemexpress.cn/batch_PDF/HY-13757A/Tamoxifen-DataSheet-MedChemExpress.pdf


Tamoxifen(他莫昔芬)

Tamoxifen(他莫昔芬)

分享到微信

×
Tamoxifen (ICI 47699) 是一種口服有效的,選擇性雌激素受體 (estrogen receptor) 調(diào)節(jié)劑 (SERM),可阻斷乳腺細(xì)胞中的雌激素作用,并可激活其他細(xì)胞,如骨骼,肝臟和子宮細(xì)胞中的雌激素活性。Tamoxifen 是一種有效的 Hsp90 激活劑,可增強(qiáng) Hsp90 分子伴侶 ATPase 的活性。Tamoxifen 還可以有效抑制傳染性 EBOV Zaire 和 Marburg (MARV),IC50 分別為 0.1 μM 和 1.8 μM。Tamoxifen 可以激活自噬 (autophagy),誘導(dǎo)凋亡 (apoptosis)。Tamoxifen 還可以誘導(dǎo) CreER(T2) 轉(zhuǎn)基因小鼠的基因敲除。

貨號(hào):HY-13757A
CAS:10540-29-1
品牌:MCE
型號(hào):HY-13757A
起訂量:1
規(guī)格::1g
價(jià)格::¥690
15906629305
在線客服
產(chǎn)品詳情

生物活性

Tamoxifen (ICI 47699) is an orally active, selective estrogen receptor modulator (SERM) which blocks estrogen action in breast cells and can activate estrogen activity in other cells, such as bone, liver, and uterine cells[1][2][3]. Tamoxifen is a potent Hsp90 activator and enhances the Hsp90 molecular chaperone ATPase activity. Tamoxifen also potent inhibits infectious EBOV Zaire and Marburg (MARV) with IC50 of 0.1 μM and 1.8 μM, respectively[5]. Tamoxifen activates autophagy and induces apoptosis[4]. Tamoxifen also can induce gene knockout of CreER(T2) transgenic mouse[6


IC50 & Target[1][4]

Estrogen receptor

HSP90


體外研究(In Vitro)

Tamoxifen (ICI 47699) shows strong inhibition of MCF-7 cells (EC50=1.41 μM) and to a lesser extent the T47D cells (EC50=2.5 μM) but does not affect the MDA-MB-231 cells


體內(nèi)研究(In Vivo)

Injection of pre-mutant mice with Tamoxifen (75 mg/kg; injected for 5 days at 6 weeks of age) results in the excision of the floxed exon and, thus, in a gene knockout

Animal Model:Aldh1l1-cre/ERT2 x Ai95 mice

Dosage:75 mg/kg

Administration:Injected for 5 days at 6 weeks of age

Result:Resulted in the excision of the floxed exon and a gene knockout.


中文名稱

他莫昔芬;三苯氧胺;它莫西芬


運(yùn)輸條件

Room temperature in continental US; may vary elsewhere


儲(chǔ)存方式

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)


溶解性數(shù)據(jù)

DMSO : 62.5 mg/mL (168.23 mM; ultrasonic and warming and heat to 60°C)

Ethanol : 50 mg/mL (134.59 mM; Need ultrasonic)

配制儲(chǔ)備液
濃度溶劑體積質(zhì)量1 mg5 mg10 mg
1 mM2.6917 mL13.4586 mL26.9172 mL
5 mM0.5383 mL2.6917 mL5.3834 mL
10 mM0.2692 mL1.3459 mL2.6917 mL
*

請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;一旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。
儲(chǔ)備液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C 儲(chǔ)存時(shí),請(qǐng)?jiān)?6 個(gè)月內(nèi)使用,-20°C 儲(chǔ)存時(shí),請(qǐng)?jiān)?1 個(gè)月內(nèi)使用。


請(qǐng)根據(jù)您的實(shí)驗(yàn)動(dòng)物和給藥方式選擇適當(dāng)?shù)娜芙夥桨浮R韵氯芙夥桨付颊?qǐng)先按照 In Vitro 方式配制澄清的儲(chǔ)備液,再依次添加助溶劑:

——為保證實(shí)驗(yàn)結(jié)果的可靠性,澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;體內(nèi)實(shí)驗(yàn)的工作液,建議您現(xiàn)用現(xiàn)配,當(dāng)天使用; 以下溶劑前顯示的百
分比是指該溶劑在您配制終溶液中的體積占比;如在配制過(guò)程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過(guò)加熱和/或超聲的方式助溶

  • 1.


    請(qǐng)依序添加每種溶劑: corn oil

    Solubility: 40 mg/mL (107.67 mM); Clear solution; Need ultrasonic


  • 2.


    請(qǐng)依序添加每種溶劑: 30% PEG400  0.5% Tween80  5% Propanediol  64.5%H2O

    Solubility: 5 mg/mL (13.46 mM); Suspended solution; Need ultrasonic


  • 3.


    請(qǐng)依序添加每種溶劑: 10% EtOH    40% PEG300    5% Tween-80    45% saline

    Solubility: 2.5 mg/mL (6.73 mM); Suspended solution; Need ultrasonic


  • 4.


    請(qǐng)依序添加每種溶劑: 10% EtOH    90% corn oil

    Solubility: ≥ 2.5 mg/mL (6.73 mM); Clear solution


  • 5.


    請(qǐng)依序添加每種溶劑: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.08 mg/mL (5.60 mM); Clear solution


  • 6.


    請(qǐng)依序添加每種溶劑: 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: 2.08 mg/mL (5.60 mM); Suspended solution; Need ultrasonic


  • 7.


    請(qǐng)依序添加每種溶劑: 10% DMSO    90% corn oil

    Solubility: ≥ 2.08 mg/mL (5.60 mM); Clear solution


  • 8.


    請(qǐng)依序添加每種溶劑: 5% DMSO    40% PEG300    5% Tween-80    50% saline

    Solubility: ≥ 0.83 mg/mL (2.23 mM); Clear solution


  • 9.


    請(qǐng)依序添加每種溶劑: 5% DMSO    95% (20% SBE-β-CD in saline)

    Solubility: 0.83 mg/mL (2.23 mM); Suspended solution; Need ultrasonic



參考文獻(xiàn)

[1]. Osborne CK. Tamoxifen in the treatment of breast cancer. N Engl J Med. 1998 Nov 26;339(22):1609-18.

[2]. Hawariah A, et al. In vitro response of human breast cancer cell lines to the growth-inhibitory effects of styrylpyrone derivative (SPD) and assessment of its antiestrogenicity. Anticancer Res. 1998 Nov-Dec;18(6A):4383-6.

[3]. Jun Nagai, et al. Hyperactivity with Disrupted Attention by Activation of an Astrocyte Synaptogenic Cue. Cell. 2019 May 16;177(5):1280-1292.e20.

[4]. Zhao R, et al. Tamoxifen enhances the Hsp90 molecular chaperone ATPase activity. PLoS One. 2010 Apr 1;5(4):e9934.

[5]. Kedjouar B, et al. Molecular characterization of the microsomal tamoxifen binding site. J Biol Chem. 2004 Aug 6;279(32):34048-61.

[6]. Feil S, et, al. Inducible Cre mice. Methods Mol Biol. 2009;530:343-63.

[7]. Laura Cooper, et al. Screening and Reverse-Engineering of Estrogen Receptor Ligands as Potent Pan-Filovirus Inhibitors. J Med Chem. 2020 Sep 4.



Data Sheet

https://file.medchemexpress.cn/batch_PDF/HY-13757A/Tamoxifen-DataSheet-MedChemExpress.pdf


選擇區(qū)號(hào)